Previously, the guidelines said the drug must be delivered within three hours of the onset of symptoms. The drug, called tissue plasminogen activator, or tPA, breaks down blood clots in the brain, and ...

(HealthDay News) — More community hospitals are giving tissue plasminogen activator (tPA) medication to stroke victims, improving their chances of survival and recovery, new research indicates. The ...

November 18, 2010 — About half of stroke patients cannot communicate their body weight (BW), only 1 in 5 relatives are able to provide this information, and a physician's or nurse's visual estimation ...

February 8, 2007 (San Francisco) — A new study shows that despite the lack of data on safety or efficacy, children with stroke are increasingly receiving treatment with tissue plasminogen activator ...

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

(HealthDay News) — Blacks, Hispanics, women, seniors on Medicare, and patients in rural areas are less likely to be treated with tissue plasminogen activator (tPA) after stroke, according to research ...

Ischemic stroke, caused by a clot in a blood vessel that cuts off blood flow to the brain, is the most common form of stroke and the second leading cause of death for those over 60. In the United ...

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. In their paper receiving ...